Subtype
Malignant Male Reproductive System Neoplasm
CI-CAN-00003180Explore in graph →
1,451 active trials27 approved drugs58 evidence items
- NCIt
- C8561
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003180Explore in graph →
Clinical trials
6,227 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (762)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00601406 | Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer | unknown | N/A | 2,200 | The Christie NHS Foundation TrustOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00758173 | Study of Genes and the Environment in Patients With Prostate Cancer Residing in the East Anglia, Trent, or West Midlands Regions of the United Kingdom | unknown | — | 2,000 | Cancer Research UKOTHER | 1 | Aug 26, 2013 |
| clinicaltrials |
| NCT00946543 | Intensity-Modulated Radiation Therapy in Treating Patients With Prostate Cancer | unknown | Phase 1 | 198 | Royal Marsden NHS Foundation TrustOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00959023 | Study of Blood and Tumor Samples From Men With an Inherited Risk of Prostate Cancer | unknown | — | 21,000 | Institute of Cancer Research, United KingdomOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00987675 | High-Intensity Focused Ultrasound Ablation in Treating Patients With Progressive Prostate Cancer | unknown | Phase 2 | 26 | University College London HospitalsOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00988130 | High-Intensity Focused Ultrasound Focal Ablation in Treating Patients With Progressive Prostate Cancer | unknown | Phase 2 | 26 | University College London HospitalsOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT01177865 | Study of Treatment Choice in Patients With Localized Prostate Cancer | unknown | N/A | 432 | University College London HospitalsOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT01193855 | Dutasteride in Treating Patients With Prostate Cancer | unknown | Phase 2 | 42 | University College London HospitalsOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00908141 | GM-CSF in Treating Patients With Relapsed Prostate Cancer | completed | Phase 2 | 17 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 23, 2013 | clinicaltrials |
| NCT01197209 | Neoadjuvant Study of In-situ REIC/Dkk-3 in Prostate Cancer | withdrawn | Phase 1 | 0 | Momotaro-Gene Inc.INDUSTRY | 1 | Aug 23, 2013 | clinicaltrials |
| NCT00685633 | Bicalutamide With or Without Enzastaurin in Treating Patients With Prostate Cancer | withdrawn | Phase 2 | 0 | Eastern Cooperative Oncology GroupNETWORK | 0 | Aug 20, 2013 | clinicaltrials |
| NCT00425334 | Safety Study of Hemospan® in Prostatectomy Patients | completed | Phase 2 | 20 | SangartINDUSTRY | 1 | Aug 19, 2013 | clinicaltrials |
| NCT01376674 | T-cell-immunity During Standard Radiotherapy in Localised Prostate Cancer | completed | — | 22 | University Hospital TuebingenOTHER | 1 | Aug 16, 2013 | clinicaltrials |
| NCT00796458 | Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancer | unknown | Phase 3 | 200 | A.O.U. San Giovanni Battista di Torino, ItalyOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00967889 | Study of Tissue, Blood, and Urine Samples From Patients With Advanced Prostate Cancer | unknown | — | — | Cancer Research UKOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00005992 | Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | unknown | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00110162 | Androgen Deprivation Therapy in Treating Patients With Prostate Cancer | unknown | Phase 3 | 2,000 | Peter MacCallum Cancer Centre, AustraliaOTHER | 2 | Aug 7, 2013 | clinicaltrials |
| NCT00554918 | Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone Therapy | completed | Phase 2 | 300 | University Hospital BirminghamOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00632138 | Pelvic Floor Muscle Training and Biofeedback or Standard Therapy in Men Who Have Undergone Radical Prostatectomy or Transurethral Resection of the Prostate | completed | Phase 3 | 800 | Aberdeen Royal InfirmaryOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT01292291 | MRI in Diagnosing Prostate Cancer | unknown | N/A | 714 | University College London HospitalsOTHER | 0 | Aug 7, 2013 | clinicaltrials |
| NCT01911741 | A Study to Compare Capsule and Tablet Forms of MDV3100 (Enzalutamide) After Administration of a Single Set Dose Under Fasted Conditions in Healthy Male Subjects | completed | Phase 1 | 55 | Astellas Pharma Europe B.V.INDUSTRY | 1 | Jul 30, 2013 | clinicaltrials |
| NCT00769431 | Evaluating Symptom Management Educational Materials for Patients With Prostate Cancer | completed | N/A | 7 | Baylor College of MedicineOTHER | 1 | Jul 26, 2013 | clinicaltrials |
| NCT01909388 | Dose Escalation to Dominant Intraprostatic Lesions (DIL) With MRI-TRUS Fusion High Dose Rate (HDR) Prostate Brachytherapy(BRAPROST) | unknown | Phase 2 | 15 | Alfonso Gomez-IturriagaOTHER | 1 | Jul 26, 2013 | clinicaltrials |
| NCT00796874 | Magnetic Resonance Imaging in Detecting Cancer Progression in Patients With Early Stage Prostate Cancer Undergoing Active Surveillance | withdrawn | N/A | 0 | Roswell Park Cancer InstituteOTHER | 0 | Jul 25, 2013 | clinicaltrials |
| NCT01905488 | Perioperative Changes of Cognitive Function According to Jugular Vein Insufficiency in Robot-assisted Prostatectomy | completed | — | 50 | Yonsei UniversityOTHER | 1 | Jul 23, 2013 | clinicaltrials |
| NCT00005627 | Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | completed | Phase 1 | — | Dana-Farber Cancer InstituteOTHER | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00562380 | AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma | completed | Phase 1 | 64 | AmgenINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT01041326 | Preoperative Radiation Therapy for High Risk Prostate Cancer | completed | Phase 1 | 15 | Duke UniversityOTHER | 1 | Jul 17, 2013 | clinicaltrials |
| NCT01901042 | Efficacy of Symbiotic in the Reduction of Acute Radiation Proctitis Symptoms | completed | Phase 2 / Phase 3 | 20 | Federal University of Mato GrossoOTHER | 0 | Jul 17, 2013 | clinicaltrials |
| NCT00028769 | S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer | completed | Phase 2 | 41 | SWOG Cancer Research NetworkNETWORK | 1 | Jul 16, 2013 | clinicaltrials |
| NCT01899391 | Periperal Blood Lymphocytes During Prostate RT | withdrawn | — | 0 | University Health Network, TorontoOTHER | 0 | Jul 15, 2013 | clinicaltrials |
| NCT00005848 | R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | completed | Phase 2 | 7 | Fox Chase Cancer CenterOTHER | 1 | Jul 11, 2013 | clinicaltrials |
| NCT00181584 | Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer | completed | Phase 2 | 60 | Massachusetts General HospitalOTHER | 1 | Jul 11, 2013 | clinicaltrials |
| NCT00455624 | Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer | completed | — | 60 | Massachusetts General HospitalOTHER | 1 | Jul 11, 2013 | clinicaltrials |
| NCT00456144 | Prospective Observation Study of Insulin Sensitivity During and After Gonadotropin Releasing Hormone Agonist Therapy for Prostate Cancer | completed | — | 36 | Massachusetts General HospitalOTHER | 1 | Jul 11, 2013 | clinicaltrials |
| NCT00738140 | Lifestyle Intervention to Improve Insulin Sensitivity and Markers of Cardiovascular Risk in Prostate Cancer Survivors | completed | Phase 2 | 15 | Massachusetts General HospitalOTHER | 1 | Jul 11, 2013 | clinicaltrials |
| NCT01547416 | The Effect of Combined General/Epidural Anesthesia Versus General Anesthesia on Diaphragmatic Function | completed | Phase 4 | 50 | Yonsei UniversityOTHER | 1 | Jul 11, 2013 | clinicaltrials |
| NCT01896713 | The Value of MultiSpectral 3 Tesla MRI in Active Surveillance of Prostate Cancer | completed | N/A | 81 | Sunnybrook Health Sciences CentreOTHER | 1 | Jul 11, 2013 | clinicaltrials |
| NCT00003517 | Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer | withdrawn | Phase 2 | 0 | Burzynski Research InstituteOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00030277 | High-Intensity Focused Ultrasound in Treating Patients With Locally Recurrent Prostate Cancer | completed | Phase 1 | 20 | Focus SurgeryINDUSTRY | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00030290 | Ultrasound in Treating Patients With Prostate Cancer Confined to the Prostate | completed | Phase 1 | — | Focus SurgeryINDUSTRY | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00081172 | Radiolabeled Monoclonal Antibody in Treating Patients With Progressive Metastatic Androgen-Independent Adenocarcinoma (Cancer) of the Prostate | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00084565 | Paclitaxel, Topotecan, and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate Cancer | withdrawn | Phase 2 | 0 | Fox Chase Cancer CenterOTHER | 0 | Jul 10, 2013 | clinicaltrials |
| NCT00003103 | Chemotherapy in Treating Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 57 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT01351688 | An Open Label Prostate Cancer Study in Japanese Patients | completed | Phase 1 | 13 | AstraZenecaINDUSTRY | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00485303 | An Efficacy and Safety Study of Abiraterone Acetate and Prednisone in Participants With Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy | completed | Phase 2 | 58 | Cougar Biotechnology, Inc.INDUSTRY | 2 | Jul 2, 2013 | clinicaltrials |
| NCT00003104 | Computer Planned Radiation Therapy in Treating Patients With Prostate Cancer | completed | Phase 2 | 50 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00003367 | Diet and PSA Levels in Patients With Prostate Cancer | completed | Phase 3 | 154 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00006078 | Lycopene In Preventing of Prostate Cancer | completed | Phase 1 | — | University of Illinois at ChicagoOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00082927 | Single-Dose Local Radiation Therapy Compared With Ibandronate in Treating Patients With Localized Metastatic Bone Pain | completed | Phase 3 | 580 | Cancer Research UKOTHER | 1 | Jun 26, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Aug 26, 2013source: clinicaltrials